BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30700444)

  • 1. Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis.
    Zhu Y; Wei Y; Zhang R; Dong X; Shen S; Zhao Y; Bai J; Albanes D; Caporaso NE; Landi MT; Zhu B; Chanock SJ; Gu F; Lam S; Tsao MS; Shepherd FA; Tardon A; Fernández-Somoano A; Fernandez-Tardon G; Chen C; Barnett MJ; Doherty J; Bojesen SE; Johansson M; Brennan P; McKay JD; Carreras-Torres R; Muley T; Risch A; Wichmann HE; Bickeboeller H; Rosenberger A; Rennert G; Saliba W; Arnold SM; Field JK; Davies MPA; Marcus MW; Wu X; Ye Y; Le Marchand L; Wilkens LR; Melander O; Manjer J; Brunnström H; Hung RJ; Liu G; Brhane Y; Kachuri L; Andrew AS; Duell EJ; Kiemeney LA; van der Heijden EH; Haugen A; Zienolddiny S; Skaug V; Grankvist K; Johansson M; Woll PJ; Cox A; Taylor F; Teare DM; Lazarus P; Schabath MB; Aldrich MC; Houlston RS; McLaughlin J; Stevens VL; Shen H; Hu Z; Dai J; Amos CI; Han Y; Zhu D; Goodman GE; Chen F; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):935-942. PubMed ID: 30700444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating C-reactive protein increases lung cancer risk: Results from a prospective cohort of UK Biobank.
    Ji M; Du L; Ma Z; Xie J; Huang Y; Wei X; Jiang X; Xu J; Yin R; Wang Y; Dai J; Jin G; Xu L; Zhu C; Hu Z; Ma H; Zhu M; Shen H
    Int J Cancer; 2022 Jan; 150(1):47-55. PubMed ID: 34449869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study.
    Liu J; Zhou H; Zhang Y; Huang Y; Fang W; Yang Y; Hong S; Chen G; Zhao S; Chen X; Zhang Z; Shen J; Xian W; Zhan J; Zhao Y; Hou X; Ma Y; Zhou T; Zhao H; Zhang L
    Cancer Med; 2019 Apr; 8(4):1817-1825. PubMed ID: 30741477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
    de Jong C; Deneer VHM; Kelder JC; Ruven H; Egberts TCG; Herder GJM
    Thorac Cancer; 2020 Jul; 11(7):1790-1800. PubMed ID: 32383328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung: Study in a tertiary care hospital.
    Ghosh M; Mukhopadhyay M; Das C; Chatterjee S; Naskar BG
    J Cancer Res Ther; 2021; 17(6):1389-1396. PubMed ID: 34916369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.
    Qu Y; Yang Y; Ma D; Xiao W
    Oncol Rep; 2012 Apr; 27(4):1277-83. PubMed ID: 22246423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based Chemotherapy.
    Singh A; Singh N; Behera D; Sharma S
    Pathol Oncol Res; 2019 Oct; 25(4):1327-1340. PubMed ID: 29209987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population.
    Niu X; Chen Z; Shen S; Liu Y; Zhou D; Zhang J; Li Z; Yu Y; Liao M; Lu S; He L
    J Thorac Oncol; 2010 May; 5(5):658-66. PubMed ID: 20234319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preoperative platelet distribution width: A predictive factor of the prognosis in patients with non-small cell lung cancer.
    Liu C; Zhang H; Qi Q; Zhang B; Yue D; Wang C
    Thorac Cancer; 2020 Apr; 11(4):918-927. PubMed ID: 32061027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mendelian randomization study of telomere length and lung cancer risk in East Asian population.
    Cao X; Huang M; Zhu M; Fang R; Ma Z; Jiang T; Dai J; Ma H; Jin G; Shen H; Du J; Xu L; Hu Z
    Cancer Med; 2019 Dec; 8(17):7469-7476. PubMed ID: 31605466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR array: uses in the detection of plasma EGFR mutations in non-small cell lung cancer patients.
    Yam I; Lam DC; Chan K; Chung-Man Ho J; Ip M; Lam WK; Chan TK; Chan V
    J Thorac Oncol; 2012 Jul; 7(7):1131-40. PubMed ID: 22610259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer.
    Rice SJ; Belani CP
    PLoS One; 2021; 16(12):e0260988. PubMed ID: 34855926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between idiopathic pulmonary fibrosis and risk of different pathological types of lung cancer: a Mendelian randomization study.
    Zheng H; Nie D; Huang X
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7751-7757. PubMed ID: 37009919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
    Mo D; He F
    Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case/Control Study:
    Zhang L; Li X; Quan X; Tian W; Yang X; Zhou B
    DNA Cell Biol; 2019 Dec; 38(12):1452-1459. PubMed ID: 31603707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Three Polymorphisms in
    Liu F; Li X; Liu P; Quan X; Zheng C; Zhou B
    DNA Cell Biol; 2019 Dec; 38(12):1437-1443. PubMed ID: 31580742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NEAT1 polymorphisms and lung cancer susceptibility in a Chinese Northeast Han Population: A case-control study.
    Wang S; Cui Z; Li H; Li J; Lv X; Yang Z; Gao M; Bi Y; Zhang Z; Zhou B; Yin Z
    Pathol Res Pract; 2019 Dec; 215(12):152723. PubMed ID: 31704150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort.
    Ding N; Pang Z; Shen H; Ni Y; Du J; Liu Q
    Sci Rep; 2016 Oct; 6():34823. PubMed ID: 27703265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.